Jetex Annual Review Dubai, United Arab Emirates, Dec. 29, 2022 (GLOBE NEWSWIRE) — The business aviation industry is currently going through the biggest transition in history, accelerated by the digitalisation, accessibility, and the exceptional travel conveniences that it offers against the backdrop of a gradual recovery from the health crisis. In many ways, it reflects […]
Highlights Include New Product Launches, Numerous Industry Partnerships, and a Ramping Up of Trade Surveillance Services New York, NY, Dec. 29, 2022 (GLOBE NEWSWIRE) — Abel Noser Holdings, the market leader in institutional trade analytics and agency-only trading solutions, has many notable achievements to look back on this year as 2022 comes to a close. […]
The world is getting warmer, winters included. The United States, however, has experienced severe winter storms in recent years, and experts are taking a closer look at the link between these extreme cold events and climate change. While the link between global warming and heat waves is very direct, the behavior of winter storms is … Read more
As COVID-19 infections surge in China, the U.S. Centers for Disease Control and Prevention is considering sampling wastewater taken from international aircraft to track any emerging new variants, the agency told Reuters. Such a policy would offer a better solution to tracking the virus and slowing its entry into the United States than new travel … Read more
At the ongoing 4th Ordinary Session of the National Assembly, people representatives have urged the government to ensure the country’s economy grows by at least 4.5% and per capita incomes and GNI are increased. Members of the National Assembly have noted that it is obvious that several sectors and provinces have potentials and are likely … Read more
SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces the online publication in New England Journal (NEJM) of the Phase 3 trial (NCT05341609) comparing the efficacy and safety […]